Combining Gamma-Secretase Inhibitors with Platinum Compounds Kills Colorectal Cancer Cells
Author Information
Author(s): Tamara Aleksic, Stephan Feller
Primary Institution: Oxford University Department of Medical Oncology
Hypothesis
Notch signaling is required in colorectal cancer cells and its inhibition can enhance the effects of platinum compounds.
Conclusion
Gamma-secretase inhibition activates MAP kinases and enhances cell death induced by platinum compounds in colorectal cancer cell lines.
Supporting Evidence
- 63 out of 64 colorectal cancer cell lines showed the presence of Notch1 intracellular domain fragments.
- Inhibition of Notch signaling did not significantly affect cell growth or survival in most cell lines.
- Combining gamma-secretase inhibitors with cisplatin led to enhanced cell death in a subset of colorectal cancer lines.
Takeaway
This study found that blocking a certain cancer signal can help make chemotherapy work better in some colorectal cancer cells.
Methodology
The study analyzed 64 colorectal cancer cell lines for Notch signaling and tested the effects of gamma-secretase inhibitors combined with platinum compounds.
Limitations
The study did not explore the effects of gamma-secretase inhibitors on all colorectal cancer subtypes and the mechanism of Erk activation remains unclear.
Participant Demographics
The study involved 64 human colorectal cancer cell lines derived from 63 different patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website